Perspective Therapeutics, Inc.
General ticker "CATX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $256.6M (TTM average)
Perspective Therapeutics, Inc. follows the US Stock Market performance with the rate: 4.2%.
Estimated limits based on current volatility of 2.5%: low 2.90$, high 3.05$
Factors to consider:
- Total employees count: 140 as of 2024
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.76$, 4.51$]
- 2026-12-31 to 2027-12-31 estimated range: [1.95$, 4.80$]
Financial Metrics affecting the CATX estimates:
- Positive: with PPE of -2.0 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 20.30 > -0.60
- Negative: negative Net income
- Positive: Shareholder equity ratio, % of 77.55 > 64.29
- Positive: Interest expense per share per price, % of 0.19 <= 0.73
- Positive: Inventory ratio change, % of -47.26 <= -0.75
Short-term CATX quotes
Long-term CATX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1.43MM | $1.43MM | $0.88MM |
| Operating Expenses | $42.38MM | $92.31MM | $114.45MM |
| Operating Income | $-40.94MM | $-90.89MM | $-113.56MM |
| Non-Operating Income | $0.83MM | $10.46MM | $9.14MM |
| Interest Expense | $0.00MM | $0.00MM | $0.38MM |
| R&D Expense | $21.31MM | $41.64MM | $84.22MM |
| Income(Loss) | $-40.11MM | $-80.43MM | $-104.43MM |
| Taxes | $-2.65MM | $-2.10MM | $-0.79MM |
| Other Income(Loss) | $-9.05MM | $-0.95MM | $0.51MM |
| Net Income(Loss)* | $-46.51MM | $-79.28MM | $-103.12MM |
| Stockholders Equity | $75.18MM | $290.67MM | $207.03MM |
| Assets | $97.89MM | $341.10MM | $266.97MM |
| Operating Cash Flow | $-36.91MM | $-18.29MM | $-82.48MM |
| Capital expenditure | $1.07MM | $54.41MM | $12.75MM |
| Investing Cash Flow | $24.37MM | $-218.93MM | $41.23MM |
| Financing Cash Flow | $0.79MM | $289.38MM | $10.30MM |
| Earnings Per Share** | $-0.85 | $-1.23 | $-1.40 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.